• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期给予前列腺素 E 对动脉导管形态变化的影响。

Effect of Long-term Administration of Prostaglandin E on Morphologic Changes in Ductus Arteriosus.

机构信息

Department of Cardiovascular Surgery, Kobe Children's Hospital, Hyogo, Japan.

Department of Cardiovascular Surgery, Kobe Children's Hospital, Hyogo, Japan.

出版信息

Ann Thorac Surg. 2020 Dec;110(6):2088-2095. doi: 10.1016/j.athoracsur.2020.02.053. Epub 2020 Apr 2.

DOI:10.1016/j.athoracsur.2020.02.053
PMID:32246933
Abstract

BACKGROUND

To improve survival of patients with hypoplastic left heart syndrome, combination therapy with bilateral pulmonary artery banding and prostaglandin E (PGE)-mediated ductal patency was developed as an alternative for high-risk neonates in Japan. However, the effect of long-term PGE administration on ductus arteriosus remains unclear. Synchrotron radiation-based X-ray phase-contrast tomography (XPCT) enables clear visualization of soft tissues at an approximate spatial resolution of 12.5 μm. We aimed to investigate morphologic changes in ductus arteriosus after long-term PGE infusion using XPCT.

METHODS

Seventeen ductus arteriosus tissue samples from patients with hypoplastic left heart syndrome were obtained during the Norwood procedure. The median duration of lipo-prostaglandin E (lipo-PGE) administration was 48 days (range, 3 to 123). Structural analysis of ductus arteriosus was performed and compared with conventional histologic analysis.

RESULTS

The XPCT was successfully applied to quantitative measurements of ductal media. Significant correlation was found between the duration of lipo-PGE infusion and mass density of ductal media (R = 0.723, P = .001). The duration of lipo-PGE administration was positively correlated with elastic fiber staining (R = 0.799, P < .001) and negatively correlated with smooth muscle formation (R = -0.83, P < .001). No significant increase in intimal cushion formation was found after long-term lipo-PGE administration. Expression of ductus arteriosus dominant PGE-receptor EP4 almost disappeared in specimens when lipo-PGE was administered over 3 days.

CONCLUSIONS

Disorganized elastogenesis and little intimal cushion formation after long-term lipo-PGE administration suggest that ductus arteriosus remodeled to the elastic artery phenotype. Because EP4 was downregulated and ductus arteriosus exhibited elastic characteristics, the dosage of lipo-PGE might be decreased after a definite administration period.

摘要

背景

为提高左心发育不全综合征患者的生存率,在日本,对于高危新生儿,开发了双侧肺动脉带扎和前列腺素 E(PGE)介导的动脉导管开放联合治疗作为替代方案。然而,长期 PGE 给药对动脉导管的影响尚不清楚。基于同步加速器的 X 射线相衬断层摄影术(XPCT)可在约 12.5μm 的近似空间分辨率下清晰地显示软组织。我们旨在使用 XPCT 研究长期 PGE 输注后动脉导管的形态变化。

方法

在 Norwood 手术期间,从患有左心发育不全综合征的患者中获得了 17 个动脉导管组织样本。脂肪前列腺素 E(lipo-PGE)给药的中位数持续时间为 48 天(范围 3 至 123 天)。对动脉导管进行结构分析,并与常规组织学分析进行比较。

结果

XPCT 成功应用于导管管腔的定量测量。脂肪 PGE 输注时间与管腔介质的质量密度之间存在显著相关性(R=0.723,P=0.001)。脂肪 PGE 给药时间与弹性纤维染色呈正相关(R=0.799,P<0.001),与平滑肌形成呈负相关(R=-0.83,P<0.001)。长期脂肪 PGE 给药后未见内膜垫形成明显增加。当脂肪 PGE 给药超过 3 天时,动脉导管中占主导地位的 PGE 受体 EP4 的表达几乎消失。

结论

长期脂肪 PGE 给药后动脉导管出现结构紊乱的弹性生成和少量内膜垫形成,表明动脉导管重塑为弹性动脉表型。由于 EP4 下调且动脉导管呈现弹性特征,因此在确定给药期后,脂肪 PGE 的剂量可能会减少。

相似文献

1
Effect of Long-term Administration of Prostaglandin E on Morphologic Changes in Ductus Arteriosus.长期给予前列腺素 E 对动脉导管形态变化的影响。
Ann Thorac Surg. 2020 Dec;110(6):2088-2095. doi: 10.1016/j.athoracsur.2020.02.053. Epub 2020 Apr 2.
2
Vasodilating effect and tissue accumulation of prostaglandin E1 incorporated in lipid microspheres on the rat ductus arteriosus.脂质微球包裹的前列腺素E1对大鼠动脉导管的血管舒张作用及组织蓄积
Jpn J Pharmacol. 1999 Sep;81(1):107-14. doi: 10.1254/jjp.81.107.
3
Echocardiographic evaluation of the ductal morphology in patients with refractoriness to lipo-prostaglandin E1 therapy.对前列腺素E1脂质体治疗耐药患者的导管形态进行超声心动图评估。
Pediatr Int. 2000 Apr;42(2):134-8. doi: 10.1046/j.1442-200x.2000.01195.x.
4
Successful use of oral prostaglandin E1 derivative for maintaining ductus-dependent systemic circulation in a neonate with trisomy 18.口服前列腺素E1衍生物成功用于维持18三体综合征新生儿的动脉导管依赖性体循环。
Cardiol Young. 2019 Sep;29(9):1222-1224. doi: 10.1017/S1047951119001902. Epub 2019 Aug 22.
5
Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.在应用脂微球前列地尔E1治疗膈疝期间动脉导管瘤样扩张。
Eur J Pediatr. 1993 Nov;152(11):877-9. doi: 10.1007/BF01957520.
6
An approach to predict the ductus-arteriosus dilating effect induced by lipo-prostaglandin E1 in newborn rats lacking plasma concentration-time data by the pharmacological response kinetic model.一种通过药理反应动力学模型预测缺乏血浆浓度-时间数据的新生大鼠中脂微球载体前列腺素E1诱导的动脉导管扩张效应的方法。
Biol Pharm Bull. 2003 Feb;26(2):210-5. doi: 10.1248/bpb.26.210.
7
Oral prostaglandin E1 derivative (OP-1206) in an infant with double outlet right ventricle and pulmonary stenosis. Effect on ductus-dependent pulmonary circulation.口服前列腺素E1衍生物(OP - 1206)用于一名患有右心室双出口及肺动脉狭窄的婴儿。对依赖动脉导管的肺循环的影响。
Jpn Heart J. 1991 Sep;32(5):735-40. doi: 10.1536/ihj.32.735.
8
Formation of biologically active 13,14-dihydro-prostaglandin E1 during intravenous infusion of prostaglandin E1 in newborns with ductus arteriosus-dependent congenital heart disease.在患有动脉导管依赖性先天性心脏病的新生儿静脉输注前列腺素E1期间生物活性13,14-二氢前列腺素E1的形成。
Br J Clin Pharmacol. 1992 Mar;33(3):323-5. doi: 10.1111/j.1365-2125.1992.tb04044.x.
9
Histopathology of the ductus arteriosus after prostaglandin E1 administration in ductus dependent cardiac anomalies.前列腺素E1用于动脉导管依赖型心脏畸形治疗后动脉导管的组织病理学
Br Heart J. 1978 Mar;40(3):215-20. doi: 10.1136/hrt.40.3.215.
10
Nursing care of the neonate receiving prostaglandin E1 therapy.接受前列腺素E1治疗的新生儿的护理
Neonatal Netw. 1993 Jun;12(4):17-22.

引用本文的文献

1
Point-of-Care Ultrasound Optimizes the Preoperative Use of Prostaglandin E1 in Infants With Transposition of the Great Arteries.床旁超声优化前列腺素E1在大动脉转位婴儿术前的应用。
Rev Cardiovasc Med. 2025 Aug 27;26(8):39250. doi: 10.31083/RCM39250. eCollection 2025 Aug.
2
Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study.前列腺素E1累积剂量决定等待心脏手术的足月儿和近足月儿的胃肠道不良反应:一项回顾性队列研究
Children (Basel). 2023 Sep 19;10(9):1572. doi: 10.3390/children10091572.
3
Efficacy of administrative intervention for neurosurgical patients with off-label use of alprostadil lipid microsphere.
神经外科患者使用前列地尔脂微球超说明书用药的行政干预效果。
Sci Rep. 2022 Sep 13;12(1):15363. doi: 10.1038/s41598-022-19717-0.